GW Pharma shares soar 21% on rising revenues

Mugglehead
By Jared GnamNov 3, 2020, 6:34 pm211 pts
Shares of GW Pharmaceuticals plc (Nasdaq: GWPH) rose 21 per cent Tuesday as the cannabinoid drugmaker reported rising third-quarter revenues, and the launch of a Phase 3 trial for a multiple sclerosis treatment. The U.K.-based company said net revenue for the three months ended Sept. 30 was US$137.1 million, up…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Texas gov. makes final hour decision on hemp ban 68

Pura Vida! Costa Rica officially starts medical cannabis rollout after years of delays 61

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.